Skip to main content

Published locations for Moderate-to-severe atopic dermatitis: Tralokinumab with or without TCS effective and safe in North American population

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Moderate-to-severe atopic dermatitis: Tralokinumab with or without TCS effective and safe in North American population

User login

  • Reset your password
  • /content/moderate-severe-atopic-dermatitis-tralokinumab-or-without-tcs-effective-and-safe-north
  • /dermatology/article/258854/atopic-dermatitis/moderate-severe-atopic-dermatitis-tralokinumab-or